Loratadine: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===[[Allergic rhinitis]]=== | ===[[Allergic rhinitis]]=== | ||
*10 mg | *10 mg PO once daily, OR | ||
*5 mg twice daily | *5 mg twice daily | ||
*Do not exceed 10 mg in 24 hours | *Do not exceed 10 mg in 24 hours | ||
===[[Urticaria]]=== | |||
*10 mg PO once daily | |||
**Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits. | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 21:31, 20 May 2026
Administration
- Type: H1 antagonists (second generation)
- Dosage Forms: Tablets (chewable or orally disintegrating tablets [ODTs]), liquid-filled capsules, or a syrup (1 mg/mL solution)
- Routes of Administration: Oral
- Common Trade Names: Claritin
Adult Dosing
Allergic rhinitis
- 10 mg PO once daily, OR
- 5 mg twice daily
- Do not exceed 10 mg in 24 hours
Urticaria
- 10 mg PO once daily
- Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.
Pediatric Dosing
Allergic rhinitis
- Children aged 6 and older
- 10 mg PO once daily, OR
- Children aged 2 to 5
- 5 mg PO once daily
- Do not exceed 10 mg in 24 hours
- The ODT formulation is not recommended for younger children.
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: